Biden Teams Up With Bernie Sanders to Promote Lower Health Care Costs

‘Finally, we beat Big Pharma,’ President Biden said.
Biden Teams Up With Bernie Sanders to Promote Lower Health Care Costs
(L-R) President Joe Biden gestures as Senator Bernie Sanders (I-Vt.) looks on during an event about lowering healthcare costs in the Indian Treaty Room of the White House in Washington, D.C., on April 3, 2024. Jim Watson/AFP
Emel Akan
Updated:

WASHINGTON—President Joe Biden held a White House meeting on Wednesday to highlight his administration’s continued fight against Big Pharma and efforts to lower prescription drug costs.

Sen. Bernie Sanders (I-Vt.), his one-time 2020 Democratic primary opponent, joined President Biden to highlight his efforts to cut healthcare costs—particularly his recent steps to lower the cost of inhalers.

“You and I have been fighting this for 25 years,” President Biden said to Mr. Sanders during the event. “Finally, we beat Big Pharma, finally.”

President Biden criticized drug companies for charging “exorbitant prescription drug prices.”

He also highlighted how the Inflation Reduction Act is lowering drug costs for seniors on Medicare.

Speaking at the event, Mr. Sanders said that Americans “are sick and tired of paying by far the highest prices in the world for prescription drugs.”

“On average, we pay over three times as much as the people of other major countries for brand-name prescription drugs, and in some cases, we are paying 10 or 20 times more than people around the world for the exact same product,” he added.

President Biden praised Mr. Sanders’ efforts to take on pharmaceutical companies that charge unreasonably high prices for asthma inhalers.

Asthma impacts 27 million Americans, according to the White House, including more than four million kids.

“Many asthma medications may have been on the market for more than 25 years. They cost less than $5 to make,” President Biden said.

However, in the United States, the list price for inhalers has been between $200 and $600 for those without insurance.

During the event, Federal Trade Commission Chair Lina Khan spoke about the “bogus patents” of pharmaceutical companies that keep the costs of inhalers elevated. She said that after the administration put these pharma companies on notice, three of the top four companies announced that the maximum pricing for asthma inhalers would be $35 beginning in June.

During his speech, President Biden proposed to extend the $2,000 cap on prescription drug costs and $35 insulin to all Americans, while also allowing Medicare to negotiate prices for at least 50 drugs a year.

“I think we should be more aggressive,” he said.

The president also said that his efforts to deliver lower healthcare costs are in stark contrast to the visions of former President Donald Trump and Republicans in Congress.

He criticized Republicans for seeking to terminate the Affordable Care Act and cut Social Security and Medicare.

The event comes as President Biden continues to struggle to overcome his low approval ratings.

A new Wall Street Journal poll showed that President Biden is trailing his rival, former President Trump, in six of the seven battleground states in the 2024 election. Voters continue to express broad dissatisfaction with the U.S. economy and deep concerns about his capabilities and job performance, according to the poll.

President Trump is leading by 2 to 8 percentage points in six states—Pennsylvania, Michigan, Arizona, Georgia, Nevada, and North Carolina—on a sample ballot with third-party and independent candidates. When voters only had to choose between him and Joe Biden, the results remained similar.

In Wisconsin, however, Joe Biden leads by three points on the multi-candidate ballot. The two candidates are tied in a head-to-head matchup in Wisconsin.

Emel Akan
Emel Akan
reporter
Emel Akan is a senior White House correspondent for The Epoch Times, where she covers the Biden administration. Prior to this role, she covered the economic policies of the Trump administration. Previously, she worked in the financial sector as an investment banker at JPMorgan. She graduated with a master’s degree in business administration from Georgetown University.
twitter
Related Topics